NÖK Therapeutics, Inc.
PrivateLast Round
Corporate Funding
Dec 23, 2024
Total Funding Raised
$524,500
Company Overview
NÖK Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Ormond Beach, Florida. It has raised $524,500.
NÖK Therapeutics, Inc. is a biotechnology company that develops autologous natural killer (NK) cell-based cancer therapies designed to be administered without lymphodepleting chemotherapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NÖK Therapeutics, Inc. Comparables
Compare NÖK Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NKGen Biotech, Inc. | 74% | |
| ImmunityBio | 70% | |
| Acepodia | 66% |
For institutional investors. Book with your work email.
NÖK Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 23, 2024 | ||||
| Crowdfunding | Jun 27, 2024 |
For institutional investors. Book with your work email.
NÖK Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hilton Family Office | Corporate Funding, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 23, 2024
$10M raised with J. Bradley Hilton leading.
- Jun 27, 2024
Raised $1.4K in a crowdfunding round.
For institutional investors. Book with your work email.
NÖK Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NÖK Therapeutics, Inc.'s valuation, stock price, and market status.
Is NÖK Therapeutics, Inc. a public or private company?
NÖK Therapeutics, Inc. is a private company.
What is the current stock price of NÖK Therapeutics, Inc.?
NÖK Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks NÖK Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NÖK Therapeutics, Inc. worth (valuation)?
Valuation information for NÖK Therapeutics, Inc. is not publicly available.
Can I buy NÖK Therapeutics, Inc. stock?
NÖK Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NÖK Therapeutics, Inc.'s last funding round?
NÖK Therapeutics, Inc.'s most recent funding round was Corporate Funding on December 23, 2024.
Who are the main investors in NÖK Therapeutics, Inc.?
Key investors in NÖK Therapeutics, Inc. include Hilton Family Office.
Will NÖK Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for NÖK Therapeutics, Inc..
How can I track NÖK Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in NÖK Therapeutics, Inc.'s shares on secondary markets.